Global Research Nonprofit CureDuchenne Joins Pfizer to Host Free Webinar on Pfizer?s Advancement to Phase III Gene Therapy Clinical Trial

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--CureDuchenne, the leading global nonprofit focused on finding a cure for Duchenne muscular dystrophy, will co-host a free webinar with Pfizer to discuss their advancement to Phase III Clinical Trial for PF-06939926. The webinar will take place on Wednesday, March 11 at 11:00am PT/2:00pm ET and features Dr. Beth Belluscio, Pfizer Global Clinical Lead for Rare Neurological Disorders, discussing the Phase 3 study of PF-06939926, a gene therapy for Duchenne m

Click to view original post